Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Vascular Pharmacology|November 8, 2005
JANUS under stress--role of JAK/STAT signaling pathway in vascular diseasesKarsten Grote, Maren Luchtefeld, Bernhard SchiefferThescientificworldjournal|April 26, 2011
Toll-like receptors in angiogenesisKarsten Grote, Harald Schütt, Bernhard SchiefferMaterials (Basel, Switzerland)|April 28, 2023
Cellular and Systemic Effects of Micro- and Nanoplastics in Mammals-What We Know So FarKarsten Grote, Fabian Brüstle, Ann-Kathrin VlacilVascular Pharmacology|December 16, 2018
Variety matters: Diverse functions of monocyte subtypes in vascular inflammation and atherogenesisAnn-Kathrin Vlacil, Jutta Schuett, Bernhard Schieffer, et al.Thrombosis and Haemostasis|August 5, 2009
How much is too much? Interleukin-6 and its signalling in atherosclerosisHarald Schuett, Maren Luchtefeld, Christina Grothusen, et al.Immunology Letters|February 6, 2007
Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependentAnke Lührmann, Karsten Grote, Michael Stephan, et al.Journal of Vascular Research|February 11, 2010
Mechanical stress modulates SOCS-1 expression in human vascular smooth muscle cellsMarc Dangers, Julia Kiyan, Karsten Grote, et al.Blood|April 13, 2007
The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regenerationKarsten Grote, Gustavo Salguero, Matthias Ballmaier, et al.International Journal of Molecular Sciences|March 13, 2024
Cathelicidin Antimicrobial Peptide Levels in Atherosclerosis and Myocardial Infarction in Mice and HumanAlexandra Höpfinger, Andreas Schmid, Thomas Karrasch, et al.The Journal of Allergy and Clinical Immunology|December 26, 2024
Long COVID: Pathophysiology, current concepts, and future directionsChrysanthi Skevaki, Charalampos D Moschopoulos, Paraskevi C Fragkou, et al.Pageof 6